Medivation Announces Expiration of Hart-Scott-Rodino Waiting ... - MarketWatch
Medivation Announces Expiration of Hart-Scott-Rodino Waiting ... MarketWatch - Under the collaboration, Medivation and Pfizer have agreed to jointly develop and commercialize Dimebon for the treatment of Alzheimer's disease and ... |
Original post: Medivation Announces Expiration of Hart-Scott-Rodino Waiting ... - MarketWatch by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment